Important Safety Information
- In clinical studies, common adverse events were injection-site
reactions (pain, redness, swelling, or increase in arm circumference),
headache, fatigue, and gastrointestinal symptoms - Severe allergic reaction after a previous dose of BOOSTRIX or encephalopathy within 7 days of a previous pertussis antigen-containing vaccine is a contraindication
- The decision to give BOOSTRIX should be based on benefits and
risks if Guillain-Barré syndrome occurs within 6 weeks of receipt of a
prior tetanus toxoid-containing vaccine, or if progressive or unstable neurologic disorders exist - Persons who experienced an Arthus-type hypersensitivity reaction following a previous dose of tetanus toxoid-containing vaccine should not receive BOOSTRIX unless 10 years have elapsed
- The prefilled syringes contain dry natural latex rubber that may cause allergic reactions
Indication
BOOSTRIX is indicated for active booster immunization against tetanus, diphtheria, and pertussis as a single dose in individuals 10 through 64 years of age.
Important Safety Information
- In clinical studies, common adverse events were injection-site reactions (pain, redness, swelling, or increase in arm circumference), headache, fatigue, and gastrointestinal symptoms.
- Severe allergic reaction after a previous dose of BOOSTRIX or encephalopathy within 7 days of a previous pertussis antigen-containing vaccine is a contraindication.
- The decision to give BOOSTRIX should be based on benefits and risks if Guillain-Barré syndrome occurs within 6 weeks of receipt of a prior tetanus toxoid-containing vaccine, or if progressive or unstable neurologic disorders exist.
- Persons who experienced an Arthus-type hypersensitivity reaction following a previous dose of tetanus toxoid-containing vaccine should not receive BOOSTRIX unless 10 years have elapsed.
- The prefilled syringes contain dry natural latex rubber that may cause allergic reactions.